Several centers and institutes seek applications for funding
Aug. 28, 2014
The Indiana Clinical and Translational Sciences Institute recently issued requests for applications for two pilot funding programs:
Indiana Biobank -- Request for Applications
The Indiana Biobank requests applications from researchers who wish to store biospecimens in support of pilot or feasibility studies.
The IB is a statewide resource of human biological specimens that are linked to electronic medical records whose mission is to create a collection of well characterized specimens that can serve as a research resource to enhance translational research.
This RFA seeks to expand the custom collections available through the Indiana Biobank. Applicants can request samples be collected from up to 20 individuals. The types of samples that may be collected include: blood (for RNA, plasma, serum or DNA), saliva, or urine. Applicants must provide an approved specimen collection protocol or must work with IB staff to develop a collection protocol that satisfies criteria established by the IB.
The IB currently contains samples from over 15,000 individuals, all of which are linked (with informed consent) thorough the medical record number to the Indiana Network for Patient Care. The IB has the capacity to collect specific specimens (e.g., plasma, serum, urine) to meet an investigator’s research needs. With informed consent, IB specimens can be used for broad, unspecified future research.
Three applications will be funded for up to $5,000 each. Applications are due 5 p.m. Monday, Sept. 15.
To apply, visit the Indiana CTSI grants portal and enter your institutional username and password. Applications instructions are located under "Pilot Funding for Custom Biospecimen Collection Using INDIANA BIOBANK (IB) Infrastructure - 2014.09."
Questions on the appropriate scope of proposals to Tatiana Foroud, M.D., at firstname.lastname@example.org, or Brooke Patz at email@example.com. Questions on grant submissions or budgeting to Anne Nguyen at 317-278-2874 or firstname.lastname@example.org. All other questions to email@example.com or 317-278-CTSI (2874).
The Indiana Biobanks was established in 2010 with initial support from the Lilly Endowment. Additional support is provided by the Indiana Clinical and Translational Sciences Institute, one of more than 60 institutes supported by National Institutes of Health National Center for Advancing translational Sciences.
IU Center of Excellence in Molecular Hematology Pilot and Feasibility program grant
The IU Center of Excellence in Molecular Hematology announces the availability of a new round of funding opportunity through the Pilot and Feasibility program of the Center.
Applications should focus on the molecular and cellular biology of normal murine and human hematopoietic stem and progenitor cell regulation and the hematopoietic parameters impacting the efficient use of these cells in clinical transplantation and in cellular and gene therapy. Applications will be reviewed by an internal review committee and rankings will be completed based on significance, innovation, approach, feasibility, and the prospect of obtaining extramural funding for the proposed project. Applications focused on malignant hematopoiesis will be removed from the review.
IU faculty at the rank of assistant or associate professor or an equivalent research rank are eligible. Investigators with outside funding can apply provided there is no overlap between their funded research and the proposal submitted for this mechanism. Previous recipients of CEMH Pilot and Feasibility program grants in the last cycle of funding are not eligible.
Funding for a maximum of $12,500 should be requested for supplies and fees. For more information on eligibility and application requirements, please download the complete application guidelines. Applications are due 5 p.m. Friday, Sept. 26.
Submit your application documents electronically (as single pdf containing all the required forms) to Edward F. Srour, Ph.D., at firstname.lastname@example.org and April D. Maines at email@example.com.
Fall 2014 Core Pilot Grants -- Request for Applications
The Indiana CTSI Fall 2014 Core Pilot Grants seeks applications from researchers who wish to use technologies and expertise afforded by the Indiana CTSI core facilities at Indiana University, Purdue University and the University of Notre Dame.
The program aims to promote the use of technologies and expertise afforded by the CTSI Core Facilities. Examples of eligible projects include obtaining critical preliminary data for a grant application (either new award or competing renewal), obtaining a critical reagent or resource for new studies (e.g.: a new transgenic or knockout mouse model) or pilot experiments to test a new idea or establish a new line of research.
Successful proposals will demonstrate outstanding scientific merit that can be linked to generating extramural funding or novel intellectual property (IP). Success of the program will be viewed, in part, by the fostering of new funded grants or providing significant contributions to grant renewals. Proposals will be judged with equal measure on scientific merit and the likelihood of generating new intellectual property or extramural grant support.
Applications to this program are expected to have a maximum requested amount of $10,000; projects typically are one to two years in duration.
Funding is for utilization of designated Indiana CTSI core facilities only. The Indiana CTSI website includes descriptions of all available cores at IU, Purdue and Notre Dame. The Indiana CTSI seal denotes cores eligible under this program.
The application deadline is 4 p.m. Monday, Sept. 29
Faculty from IU, Purdue and Notre Dame are eligible to apply. For university- and campus-specific eligibility guidelines, or to apply, visit the Indiana CTSI grants portal and enter your institutional username and password. Applications instructions are located under "Pilot Funding for Research Use of Core Facilities - 2014.09."
For more information, email Anne Nguyen at 317-278-2874 or firstname.lastname@example.org.